Copyright © 2013 M. Ilyas Kamboh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. The persistent presence of antiphospholipid antibodies (APA) may lead to the development of primary or secondary antiphospholipid syndrome. Although the genetic basis of APA has been suggested, the identity of the underlying genes is largely unknown. In this study, we have performed a genome-wide association study (GWAS) in an effort to identify susceptibility loci/genes for three main APA: anticardiolipin antibodies (ACL), lupus anticoagulant (LAC), and anti
ObjectiveTo investigate the associations between HLA class II genes and antiphosphatidylserine/proth...
The Antiphospholipid antibody Syndrome (APS) is characterised by recurrent thromboembolic phenomena,...
Objective: Inflammation might represent a second hit for anti-phospholipid antibody (aPL)-mediated t...
Studies on the immunogenetic predisposition to antiphospholipid syndrome (APS) and on other non gene...
Whether a genetic predisposition to develop the antiphospholipid syndrome (APS) and to produce antic...
The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence of antiph...
OBJECTIVE. To investigate the origins of antiphospholipid antibodies associated with thrombosis and ...
Thrombotic antiphospholipid syndrome is defined as a complex form of thrombophilia that is developed...
Phosphorylcholine (PC) is an epitope on oxidized low-density lipoprotein (oxLDL), apoptotic cells an...
Phosphorylcholine (PC) is an epitope on oxidized low-density lipoprotein (oxLDL), apoptotic cells an...
Abstract: Antiphospholipid antibodies (aPL) are a family of autoantibodies directed against phosphol...
Objective: To investigate whether variation in the HLA-DM gene is important in producing a group of ...
Background: Genome-wide association studies (GWAS) have become a major strategy for genetic dissecti...
Genetic factors are important in the development of APS. This is demonstrated by animal models, by t...
Antiphospholipid antibodies (aPL) are a hallmark of the antiphospholipid syndrome (APS), which is th...
ObjectiveTo investigate the associations between HLA class II genes and antiphosphatidylserine/proth...
The Antiphospholipid antibody Syndrome (APS) is characterised by recurrent thromboembolic phenomena,...
Objective: Inflammation might represent a second hit for anti-phospholipid antibody (aPL)-mediated t...
Studies on the immunogenetic predisposition to antiphospholipid syndrome (APS) and on other non gene...
Whether a genetic predisposition to develop the antiphospholipid syndrome (APS) and to produce antic...
The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence of antiph...
OBJECTIVE. To investigate the origins of antiphospholipid antibodies associated with thrombosis and ...
Thrombotic antiphospholipid syndrome is defined as a complex form of thrombophilia that is developed...
Phosphorylcholine (PC) is an epitope on oxidized low-density lipoprotein (oxLDL), apoptotic cells an...
Phosphorylcholine (PC) is an epitope on oxidized low-density lipoprotein (oxLDL), apoptotic cells an...
Abstract: Antiphospholipid antibodies (aPL) are a family of autoantibodies directed against phosphol...
Objective: To investigate whether variation in the HLA-DM gene is important in producing a group of ...
Background: Genome-wide association studies (GWAS) have become a major strategy for genetic dissecti...
Genetic factors are important in the development of APS. This is demonstrated by animal models, by t...
Antiphospholipid antibodies (aPL) are a hallmark of the antiphospholipid syndrome (APS), which is th...
ObjectiveTo investigate the associations between HLA class II genes and antiphosphatidylserine/proth...
The Antiphospholipid antibody Syndrome (APS) is characterised by recurrent thromboembolic phenomena,...
Objective: Inflammation might represent a second hit for anti-phospholipid antibody (aPL)-mediated t...